Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5189)
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,847
Price
$534.98
Total Value
$988.10K
Shares Held After
24,919
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
609
Price
$533.91
Total Value
$325.15K
Shares Held After
26,766
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
510
Price
$532.93
Total Value
$271.79K
Shares Held After
27,375
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
991
Price
$532.02
Total Value
$527.24K
Shares Held After
27,885
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$539.98
Total Value
$151.19K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
740
Price
$538.90
Total Value
$398.79K
Shares Held After
40,793
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,100
Price
$537.97
Total Value
$591.77K
Shares Held After
41,533
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,540
Price
$536.96
Total Value
$826.91K
Shares Held After
42,633
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,029
Price
$536.00
Total Value
$1.09M
Shares Held After
44,173
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,476
Price
$535.06
Total Value
$789.74K
Shares Held After
46,202
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
837
Price
$534.02
Total Value
$446.98K
Shares Held After
47,678
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
498
Price
$532.90
Total Value
$265.38K
Shares Held After
48,515
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$532.08
Total Value
$447.48K
Shares Held After
49,013
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$530.95
Total Value
$84.42K
Shares Held After
49,854
% of Holdings
0.3%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
75
Price
$156.83
Total Value
$11.76K
Shares Held After
21,233
% of Holdings
0.4%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
25,000
Price
$1.44
Total Value
$36.00K
Shares Held After
8,893,276
% of Holdings
0.3%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
280
Price
$57.17
Total Value
$16.01K
Shares Held After
52,200
% of Holdings
0.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,760
Price
$56.79
Total Value
$383.87K
Shares Held After
52,480
% of Holdings
11.4%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
23,998
Price
$30.00
Total Value
$719.94K
Shares Held After
65,925
% of Holdings
26.7%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
12
Price
$21.73
Total Value
$260.70
Shares Held After
26,885
% of Holdings
0.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
1,097
Price
$21.65
Total Value
$23.75K
Shares Held After
26,897
% of Holdings
3.9%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
37
Price
$21.72
Total Value
$803.54
Shares Held After
60,269
% of Holdings
0.1%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
3,171
Price
$21.65
Total Value
$68.65K
Shares Held After
60,306
% of Holdings
5.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.12
Total Value
$269.13K
Shares Held After
468,892
% of Holdings
3.9%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,319
Price
$5.40
Total Value
$28.72K
Shares Held After
532,091
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
311
Price
$540.17
Total Value
$167.99K
Shares Held After
8,480
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
1,414
Price
$539.25
Total Value
$762.49K
Shares Held After
8,791
% of Holdings
13.9%
UNITED THERAPEUTICS Corp (UTHR)
Thompson Tommy G — Director
Shares
275
Price
$537.62
Total Value
$147.85K
Shares Held After
10,205
% of Holdings
2.6%
IMPACT BIOMEDICAL INC. (IBO)
Macko Todd D — Chief Financial Officer
Shares
1,600
Price
$0.60
Total Value
$961.28
Shares Held After
198,122
% of Holdings
0.8%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
3,575
Price
$60.08
Total Value
$214.77K
Shares Held After
1,220,004
% of Holdings
0.3%
GLAUKOS Corp (GKOS)
Thurman Alex R. — SVP & CHIEF FINANCIAL OFFICER
Shares
2,511
Price
$106.46
Total Value
$267.32K
Shares Held After
41,967
% of Holdings
5.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
2,000
Price
$85.00
Total Value
$170.00K
Shares Held After
179,371
% of Holdings
1.1%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
160
Price
$17.53
Total Value
$2.80K
Shares Held After
5,129,340
% of Holdings
0.0%
KalVista Pharmaceuticals, Inc. (KALV)
Venrock Healthcare Capital Partners III, L.P. — 10% Owner
Shares
174,485
Price
$16.95
Total Value
$2.96M
Shares Held After
5,129,500
% of Holdings
3.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
40,000
Price
$35.10
Total Value
$1.40M
Shares Held After
25,000
% of Holdings
61.5%
Tyra Biosciences, Inc. (TYRA)
KAPLAN GILLA — Director
Shares
14,295
Price
$36.97
Total Value
$528.51K
Shares Held After
28,231
% of Holdings
33.6%
Phreesia, Inc. (PHR)
Gandhi Balaji — Chief Financial Officer
Shares
3,829
Price
$11.26
Total Value
$43.13K
Shares Held After
146,740
% of Holdings
2.5%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
26,198
Price
$50.07
Total Value
$1.31M
Shares Held After
2,918,326
% of Holdings
0.9%
Legend Biotech Corp (LEGN)
Huang Ying — Director
Shares
9,936
Price
$8.77
Total Value
$87.14K
Shares Held After
247,438
% of Holdings
3.9%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
125,000
Price
$1.40
Total Value
$175.00K
Shares Held After
8,868,276
% of Holdings
1.4%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
552
Price
$56.86
Total Value
$31.39K
Shares Held After
59,240
% of Holdings
0.9%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
4,916
Price
$56.00
Total Value
$275.32K
Shares Held After
59,792
% of Holdings
7.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,572
Price
$55.28
Total Value
$86.90K
Shares Held After
64,708
% of Holdings
2.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
833
Price
$21.47
Total Value
$17.88K
Shares Held After
25,852
% of Holdings
3.1%
ACADIA PHARMACEUTICALS INC (ACAD)
Rhodes Jennifer J — EVP, CHIEF LEGAL OFFICER, SEC
Shares
3,844
Price
$21.47
Total Value
$82.53K
Shares Held After
11,280
% of Holdings
25.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research & Dev
Shares
3,435
Price
$21.47
Total Value
$73.75K
Shares Held After
3,280
% of Holdings
51.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Owen Adams Catherine — Director
Shares
11,641
Price
$21.47
Total Value
$249.93K
Shares Held After
14,803
% of Holdings
44.0%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
4,177
Price
$21.47
Total Value
$89.68K
Shares Held After
57,299
% of Holdings
6.8%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
400
Price
$97.21
Total Value
$38.88K
Shares Held After
54,400
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
11,036
Price
$96.43
Total Value
$1.06M
Shares Held After
54,800
% of Holdings
16.8%
Showing 1051–1100 of 5189 transactions (page 22 of 104)